As a member of the Pulmonary Fibrosis Foundation Care Center Network, the UAB interstitial lung disease (ILD) program is an integrated practice unit that delivers the most advanced management plans for ILD, including idiopathic pulmonary fibrosis (IPF) and sarcoidosis. We are one of the largest sarcoidosis centers in the southeast, and our lymphangioleiomyomatosis (LAM) clinic is one of only 24 nationally. Our goal is to advance new and improved therapies to help patients with ILD live longer, healthier lives.
Other highlights include:
- One of the nation’s largest ILD centers; >1,500 clinic visits annually
- Multiple NIH-supported, investigator-initiated clinical trials, especially for IPF
- Industry-sponsored trials